Christopher Seder to Follow-Up Studies
This is a "connection" page, showing publications Christopher Seder has written about Follow-Up Studies.
Connection Strength
0.270
-
Redefining the Risk of Surgery for Clinical Stage IIIA (N2) Non-Small Cell Lung Cancer: A Pooled Analysis of the STS GTSD and ESTS Registry. Lung. 2021 06; 199(3):311-318.
Score: 0.131
-
Manubrial-clavicular-chest wall explantation to expose the anterior thoracic inlet. Ann Thorac Surg. 2014 Jan; 97(1):350-2.
Score: 0.079
-
Predictors of Major Morbidity or Mortality After Resection for Esophageal Cancer: A Society of Thoracic Surgeons General Thoracic Surgery Database Risk Adjustment Model. Ann Thorac Surg. 2016 Jul; 102(1):207-14.
Score: 0.023
-
Circulating angiogenesis biomarkers are associated with disease progression in lung adenocarcinoma. Ann Thorac Surg. 2014 Dec; 98(6):1968-75; discussion 1975.
Score: 0.021
-
Airway pressure release ventilation and successful lung donation. Arch Surg. 2011 Mar; 146(3):325-8.
Score: 0.016